A novel analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and provides an option for efficacy assessments that could accelerate drug approvals.

Authors

null

Celine Yeh

Columbia University College of Physicians and Surgeons, New York, NY

Celine Yeh , Mengxi Zhou , Neil Bapodra , Maria Rivero , Edward Jose Espinal Dominguez , Marina Moran , Dawn L. Hershman , Antonio Tito Fojo , Susan Elaine Bates

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Hormone Receptor-Positive

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 1069)

DOI

10.1200/JCO.2022.40.16_suppl.1069

Abstract #

1069

Poster Bd #

447

Abstract Disclosures